Citation Impact
Citing Papers
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
2012 Standout
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
2009
Cellular and Molecular Mechanisms of MT1-MMP-Dependent Cancer Cell Invasion
2016
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
2008
Chk2 Molecular Interaction Map and Rationale for Chk2 Inhibitors
2006 Nobel
Repression of NHE1 Expression by PPARγ Activation Is a Potential New Approach for Specific Inhibition of the Growth of Tumor Cells In vitro and In vivo
2009
A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer Patients
2005
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
2001
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
2017 Standout
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
The extracellular domain of Her2 in serum as a biomarker of breast cancer
2018
Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
2008
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Triple-Negative Breast Cancer
2010 Standout
Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis
2007
The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis
2005
Anti‐tumour/metastasis effects of the potassium‐sparing diuretic amiloride: An orally active anti‐cancer drug waiting for its call‐of‐duty?
2011
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade
2009
mTOR Signaling in Growth Control and Disease
2012 Standout
Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions
2013 StandoutNature
Sequential assembly of cell‐laden hydrogel constructs to engineer vascular‐like microchannels
2011
Protons make tumor cells move like clockwork
2009
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Molecular mechanisms of drug resistance
2005
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
2007
Physiology of Cell Volume Regulation in Vertebrates
2009
Cancer Metastasis: Building a Framework
2006 Standout
External quality control assessment in PCR diagnostics of dengue virus infections
2003
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
2012 StandoutNature
BRCA1 and acetyl‐CoA carboxylase: The metabolic syndrome of breast cancer
2007
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
2002
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
2009
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
Estrogen Receptor Analysis for Breast Cancer
2005
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
2006
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
2005
Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosis
2000
Male breast cancer
2006 Standout
Epidemiology of Lung Cancer
2013
Chk2 Oligomerization Studied by Phosphopeptide Ligation
2008 StandoutNobel
Elevated Concentration of Microvesicles Isolated from Peripheral Blood in Breast Cancer Patients
2013
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Gene-Expression Signatures in Breast Cancer
2009
Cathepsin D—Many functions of one aspartic protease
2008
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
2011
SWELL1, a Plasma Membrane Protein, Is an Essential Component of Volume-Regulated Anion Channel
2014 StandoutNobel
Is cancer a disease of self-seeding?
2006
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.
1992
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Mechanisms of Bone Metastasis
2004 Standout
EGF upregulates Na+/H+ exchanger NHE1 by post‐translational regulation that is important for cervical cancer cell invasiveness
2007
Metastatic colonization by circulating tumour cells
2016 StandoutNature
The Spatial Organization of Proton and Lactate Transport in a Rat Brain Tumor
2011
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2009 Standout
The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function
2011
The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin—one single nature
2005
DNA-protein cross-linking by trans-[PtCl2(E-iminoether)2]. A concept for activation of the trans geometry in platinum antitumor complexes
2003
LRRC8 Proteins Form Volume-Regulated Anion Channels that Sense Ionic Strength
2016 StandoutNobel
Current status of the development of trans-platinum antitumor drugs
2000
Protons extruded by NHE1: Digestive or glue?
2008
Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods
1997
Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer
2006
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Clues from cell metabolism
2010 StandoutNatureNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Advances in engineering hydrogels
2017 StandoutScience
Na + /H + exchanger‐dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation‐associated phenotypes
2000
DNA?protein crosslinks: their induction, repair, and biological consequences
2005
Intracellular pH Sensors: Design Principles and Functional Significance
2007
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Additions to Metal-Activated Organonitriles
2002 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery
2015
Mechanistic basis and clinical relevance of the role of transforming growth factor-β in cancer.
2015
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Repair of DNA–polypeptide crosslinks by human excision nuclease
2006 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
Works of Angelo Paradiso being referenced
The Na+–H+exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells
2004
C-Erbb-2 Protein Level in Tissue and Sera of Breast Cancer Patients: A Possibly Useful Clinical Correlation
2006
Differential responsiveness of proliferation and cytokeratin release to stripped serum and oestrogen in the human breast cancer cell line, MCF-7
1996
An Italian program of external quality control for quantitative assays based on real-time PCR with Taq-Man™ probes
2005
Prognostic Relevance of Mitotic Activity in Patients with Node-Negative Breast Cancer
2003
3p Microsatellite Signature in Exhaled Breath Condensate and Tumor Tissue of Patients with Lung Cancer
2007
The Impact of Body Mass Index and Type 2 Diabetes on Breast Cancer: Current Therapeutic Measures of Prevention
2004
Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer
2001
Genetic alterations in hereditary breast cancer
2004
The complexity of targeting EGFR signalling in cancer: From expression to turnover
2006
p53 and PCNA expression in advanced colorectal cancer: Response to chemotherapy and long-term prognosis
1996
Developing optimal input design strategies in cancer systems biology with applications to microfluidic device engineering
2009
Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: A multicentre study
1991
Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of β‐tubulins
2007
Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients
2000
Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer
2014
Correlation between ERICA and DCC Assay in Hormone Receptor Assessment of Human Breast Cancer
1988
Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer
2005
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
2008
3p Microsatellite Alterations in Exhaled Breath Condensate from Patients with Non–Small Cell Lung Cancer
2005
Vascular endothelial growth factor assessment in different blood fractions of gastrointestinal cancer patients and healthy controls
2004
Adjuvant hormonetherapy for slow proliferating node-negative breast cancer patients. Results of the phase III trial of NCl-Bari
2003
NHE1 promotes invadopodial ECM proteolysis through acidification of the peri‐invadopodial space
2010
Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.
1990
External Quality Assurance Program for PCR Amplification of Genomic DNA: An Italian Experience
2003
Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells.
2003
Expression of Gst-Mu Transferase in Breast Cancer Patients and Healthy Controls
1994
BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases
2007
CHARACTERIZATION OF A H-3 GNRH METHOD FOR THE MEASUREMENT OF GNRH BINDING-SITES IN HUMAN BREAST-CANCER AND BREAST-CANCER CELL-LINES
1995
In vitro antitumour activity and cellular pharmacological properties of the platinum-iminoether complex trans-[PtCl2[E-HN=C(OMe)Me]2].
1999
Protein Kinase A Gating of a Pseudopodial-located RhoA/ROCK/p38/NHE1 Signal Module Regulates Invasion in Breast Cancer Cell Lines
2005
Randomized Clinical Trial of Adjuvant Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy for Patients With Fast-Proliferating, Node-Negative Breast Cancer
2001
RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease
2008
Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
2013
EQUAL-quant: An International External Quality Assessment Scheme for Real-Time PCR
2006
Intravenous Administration of Cyclophosphamide, Methotrexate and 5-Fluorouracil in Metastatic Breast Cancer. A Pilot Study
1988
Release of the aspartyl protease cathepsin D is associated with and facilitates human breast cancer cell invasion
1997
Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer
2006
Topoisomerase-1 (topo-I) and thymidylate synthase (TS) primary tumor expression as prognostic and predictive factors for response to cpt-11 in advanced colorectal cancer (crc) patients
2001